Sun Pharma, Philogen sign pact to commercialise specialty product, NIDLEGY in Europe, Australia and…
Nidlegy, currently in Phase III clinical trials, is a new anti-cancer biopharmaceutical which is being developed by Philogen for…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
skin cancers
Virus therapy shows promise against inoperable skin cancers
The drug combination is among the first, researchers say, to demonstrate the potential value of a live common cold virus,…